IP Library › Granted Patent US 8,324,428
Granted Patent B2
US 8,324,428 · App. 12/796,212 · Granted Dec 4, 2012

Stabilized compounds having secondary structure motifs

Assignee: President and Fellows of Harvard College
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,324,428
App. No.
12/796,212
Granted
Dec 4, 2012
Kind
B2
Abstract

The present invention provides novel stabilized crosslinked compounds having secondary structure motifs, libraries of these novel compounds, and methods for the synthesis of these compounds libraries thereof. The synthesis of these novel stabilized compounds involves (1) synthesizing a peptide from a selected number of natural or non-natural amino acids, wherein said peptide comprises at least two moieties capable of undergoing reaction to promote carbon-carbon bond formation; and (2) contacting said peptide with a reagent to generate at least one crosslinker and to effect stabilization of a secondary structure motif. The present invention, in a preferred embodiment, provides stabilized p53 donor helical peptides. Additionally, the present invention provides methods for disrupting the p53/MDM2 binding interaction comprising (1) providing a crosslinked stabilized α-helical structure; and (2) contacting said crosslinked stabilized α-helical structure with MDM2.

Claims (26)

1. A compound represented by formula A:

wherein:

R 1 , R 2 and R 4 are each independently —H or a protecting group suitable for peptide synthesis;

R 3 is methyl;

R 5 is an optionally substituted moiety of the formula —CH 2 CH 2 (CH 2 ) n CH═CH 2 , wherein n is 1, 2, 3 or 4; and

said compound is in a protected form suitable for peptide synthesis.

2. The compound of claim 1 , wherein n is 1.

3. The compound of claim 1 , wherein n is 4.

4. The compound of claim 1 , wherein the absolute stereochemistry at the α-position is R.

5. The compound of claim 1 , wherein the absolute stereochemistry at the α-position is S.

6. The compound of claim 1 , wherein R 4 is —H.

7. The compound of claim 1 , wherein R 1 or R 2 is an Fmoc or a Boc protecting group.

8. The compound of claim 1 , wherein the compound is selected from the group consisting of:

and said compound is in a protected form suitable for peptide synthesis.

9. A compound represented by formula B:

wherein:

R 1 , R 2 and R 4 are each independently —H or a protecting group suitable for peptide synthesis;

R 3 is methyl; and

n is 7 or 9.

10. The compound of claim 9 , wherein the absolute stereochemistry at the α-position is R.

11. The compound of claim 9 , wherein the absolute stereochemistry at the α-position is S.

12. The compound of claim 9 , wherein said compound is selected from the group consisting of:

and

said compound is in a protected form suitable for peptide synthesis.

13. A compound selected from the group consisting of:

wherein R 1 , R 2 and R 4 are each independently —H or a protecting group suitable for peptide synthesis.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 6, 2010
From: VERDINE, GREGORY L.; SCHAFMEISTER, CHRISTIAN E.
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 024637/0430 →
Continuity (5)
Continuation 11148976 · Jun 9, 2005
Continuation 09574086 · May 18, 2000
Provisional Application 60167634 · Nov 26, 1999
Provisional Application 60134708 · May 18, 1999
Related Publication 20110028753A1 · Feb 3, 2011